http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2184971-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-24 |
| filingDate | 1996-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c003d994ad83a762dbcd17ab87ccbd42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c0e87272971de281cd6f72dc7fc2d55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72477347e95ebe09f4b902c54e16ebd1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e683dc0f6e8eb81653e79bb2c09d605b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9be44cb6d2f3130b1cacbc070eb1553a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfea3b2a3effe615be00da52332d12f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bb557b723ea9073d7a58697f652afa7 |
| publicationDate | 1997-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2184971-A1 |
| titleOfInvention | Cephalosporin derivatives |
| abstract | The present invention relates to cephalosporin derivatives of the general formula I wherein R1 is a group selected from 2-, 3- and 4-hydroxyphenyl, 2- and 3-methoxyphenyl, 4-carboxyphenyl, 4-carbamoylphenyl, 3-trifluoro-methylphenyl, 2- and 3-fluorophenyl, 3-nitrophenyl, 3-fluoro-4-hyroxyphenyl, 2-fluoro-4-hydroxyphenyl, 3-fluoro-2-hydroxy-phenyl, 3-, 4-dihydroxyhenyl, benzyl, -CHR-phenyl, 3-hydroxy-benzyl, 4-aminobenzyl, 2-, 3- and 4-fluorobenzyl, 2-, 3- and 4-methoxybenzyl, 4-nitrobenzyl, 4-carboxybenzyl, 4-trifluoromethyl-benzyl, 1-naphthyl and 2-naphthyl, all hydroxy, amino, carboxy and carbamoyl substituents optionally being substituted, or is pyridinyl mono-substituted with halogen, pyrimidyl, pyrazinyl di-substituted with lower alkyl, pyridazinyl mono-substituted with halogen, piperidinyl in which the amino group may be substituted by an acyl group, thiadiazolyl, oxo-tetrahydrofuranyl, thiophenyl mono-substituted with lower alkoxycarbonyl or carbamoyl, tetrazolyl-lower alkyl, tetrahydrofuranyl-lower alkyl, thiophenyl-lower alkyl or benzimidazolyl-lower alkyl; and R is carboxy or esterified carboxy; readily hydrolyzable esters thereof, pharmaceutically acceptable salts of said compounds and hydrates of the compounds of formula I and of their esters and salts, as well as the their use and the process for manufacturing such compounds. |
| priorityDate | 1995-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 157.